 develop tumor mice receptor transfect tumor cell number differ immunotherapeut reagent treatment leukemia graft reject certain autoimmun diseas chimer protein human n-terminu truncat form pseudomona exotoxin PE varieti cell line vitro low intermedi high affin growth lethal tumor solid tumor murin thymoma cell murin transfect line high affin surviv extens ascit model treatment day post-tumor inject athym nude mice growth aggress solid tumor extens surviv truncat toxin mutant function toxin surviv extens NK host effector unabl receptor-neg parent line lethal ascit solid tumor potent specif cytolyt reagent use arsen immunotherapeut